Citigroup
DARE icon

Citigroup’s Dare Bioscience DARE Stock Holding History

Citigroup’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$4 – 6142
2025
Q3 		$4 Buy
+2
New +$5 ﹤0.01% 5992
2022
Q2 		– Sell
-2,212
Closed -$40K – 6301
2022
Q1 		$40K Buy
+2,212
New +$41.8K ﹤0.01% 4821
2021
Q3 		– Sell
-683
Closed -$15K – 5845
2021
Q2 		$15K Hold
683
– – ﹤0.01% 5462
2021
Q1 		$14K Buy
+683
New +$16.7K ﹤0.01% 5434
2016
Q2 		– Sell
-9
Closed -$3K – 7127
2016
Q1 		$3K Sell
9
-5
-36% -$1.41K ﹤0.01% 7124
2015
Q4 		$5K Buy
+14
New +$5.81K ﹤0.01% 7025
2015
Q3 		– Hold
0
– – – 7430
2015
Q1 		– Hold
0
– – – 7228
2014
Q4 		– Hold
0
– – – 7133
2014
Q3 		– Sell
-1
Closed -$1K – 7089
2014
Q2 		$1K Buy
+1
New +$772 ﹤0.01% 6896

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citigroup's DARE Position: Q4 2025 in Review

Citigroup sold out of Dare Bioscience (DARE) in Q4 2025, closing a stake of 2 shares — an estimated $4 sold.

Citigroup first reported a position in DARE in Q2 2014 and held it in 7 quarters. The position peaked at $40K in Q1 2022. 27 funds tracked by Wall St. Rank hold DARE as of Q4 2025.

  • Citigroup reported no remaining Dare Bioscience position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 2 Dare Bioscience shares in Q4 2025, an estimated $4.
  • Citigroup first reported a position in Dare Bioscience in Q2 2014 and held it in 7 quarters.
  • Citigroup's Dare Bioscience position peaked at $40K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.